These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity. Flavin A; Azizi P; Murataeva N; Yust K; Du W; Ross R; Greig I; Nguyen T; Zhang Y; Mackie K; Straiker A Molecules; 2024 Apr; 29(8):. PubMed ID: 38675703 [TBL] [Abstract][Full Text] [Related]
5. CB1 receptor-mediated signaling underlies the hippocampal synaptic, learning, and memory deficits following treatment with JWH-081, a new component of spice/K2 preparations. Basavarajappa BS; Subbanna S Hippocampus; 2014 Feb; 24(2):178-88. PubMed ID: 24123667 [TBL] [Abstract][Full Text] [Related]
6. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. Straiker A; Wager-Miller J; Hutchens J; Mackie K Br J Pharmacol; 2012 Apr; 165(8):2660-71. PubMed ID: 22014238 [TBL] [Abstract][Full Text] [Related]
7. The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons. Murataeva N; Mackie K; Straiker A Pharmacol Res; 2012 Nov; 66(5):437-42. PubMed ID: 22921769 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells. Dalton GD; Howlett AC Br J Pharmacol; 2012 Apr; 165(8):2497-511. PubMed ID: 21518335 [TBL] [Abstract][Full Text] [Related]
10. CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. Baillie GL; Horswill JG; Anavi-Goffer S; Reggio PH; Bolognini D; Abood ME; McAllister S; Strange PG; Stephens GJ; Pertwee RG; Ross RA Mol Pharmacol; 2013 Feb; 83(2):322-38. PubMed ID: 23160940 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata. Wallmichrath I; Szabo B Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):326-34. PubMed ID: 11919658 [TBL] [Abstract][Full Text] [Related]
12. Beta-caryophyllene is a dietary cannabinoid. Gertsch J; Leonti M; Raduner S; Racz I; Chen JZ; Xie XQ; Altmann KH; Karsak M; Zimmer A Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9099-104. PubMed ID: 18574142 [TBL] [Abstract][Full Text] [Related]
13. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Daigle TL; Kearn CS; Mackie K Neuropharmacology; 2008 Jan; 54(1):36-44. PubMed ID: 17681354 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Hájos N; Freund TF Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597 [TBL] [Abstract][Full Text] [Related]
16. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors. Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605 [TBL] [Abstract][Full Text] [Related]
17. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859 [TBL] [Abstract][Full Text] [Related]
18. Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model. Straiker A; Mitjavila J; Yin D; Gibson A; Mackie K Pharmacol Res; 2015 Sep; 99():370-6. PubMed ID: 26211948 [TBL] [Abstract][Full Text] [Related]
19. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103 [TBL] [Abstract][Full Text] [Related]